Listing 1 - 10 of 484 << page
of 49
>>
Sort by

Multi
A workbook of ethical case scenarios in applied behavior analysis
Authors: ---
ISBN: 9780128158944 0128158948 9780128158937 012815893X Year: 2019 Publisher: London Academic Press, an imprint of Elsevier

Loading...
Export citation

Choose an application

Bookmark

Abstract

Those working within the field of applied behavior analysis encounter potential ethical dilemmas on a daily basis. While some challenges can be anticipated and appropriately addressed before they become unmanageable, oftentimes behavior analysts are confronted with unforeseen and novel situations that require immediate, yet careful attention. It is impossible to anticipate and plan for every eventuality. A Workbook of Ethical Case Scenarios in Applied Behavior Analysis presents over 85 real-world case scenarios commonly faced by individuals practicing applied behavior analysis. The examples range in difficulty and severity to address the unique challenges and needs of those teaching, practicing, or learning applied behavior analysis through ethics-focused coursework or preparing for the BACB® certification exam. In addition to case scenarios, the book provides detailed questions to facilitate discussion and critical thinking and offers suggestions related to the navigation of ethically precarious situations.


Book
Marketing social : De la compréhension des publics au changement de comportement
Authors: --- --- ---
ISBN: 281090748X Year: 2019 Publisher: Rennes (Avenue du Professeur Léon Bernard 35000) : Presses de l’EHESP,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Qu'est-ce que le marketing social ? Est-ce différent de la communication sociale ? Quels en sont les principes, les atouts, les outils ? Que signifient les 5 C ? En quoi une campagne de marketing social est-elle efficace, dans un programme de prévention, pour modifier les comportements de bien-être et de santé ? Quels sont les risques éthiques du développement de cette technique? Pour répondre à ces questions et à toutes celles que les acteurs de la santé se posent, cet ouvrage, fruit de la collaboration entre chercheurs et experts, combine éléments théoriques, conseils pratiques et de nombreux exemples de campagnes de marketing social parmi lesquelles « Mois sans tabac » lancée depuis 2016 en France. ? Ce livre s'adresse à tous ceux qui veulent en savoir plus sur le marketing social: acteurs de terrain, chargé·e·s de prévention et de communication, mais aussi décideurs·ses et partenaires, enseignant·e·s, chercheurs·ses et étudiant·e·s en santé, marketing et communication. Le marketing social se décline notamment pas la création d'affiches en promotion de la santé. En pleine forme regroupe 130 visuels de campagnes de promotion de la santé en France et à l'étranger.


Book
Risiko im Management : 100 Fehler, Irrtümer, Verzerrungen und wie man sie vermeidet
Author:
ISBN: 3658258357 Year: 2019 Publisher: Wiesbaden : Springer Fachmedien Wiesbaden : Imprint: Springer Gabler,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Dieses Buch stellt 100 exemplarische Fehler, Verzerrungen und Irrtümer im Risikomanagement systematisch, kompakt und anschaulich dar und gibt konkrete Praxistipps, um diese gezielt zu vermeiden. „Wenn Sie bessere Entscheidungen treffen wollen, dann lesen Sie dieses aufschlussreiche Buch von Christian Glaser, das Ihnen die Einsichten der Verhaltensökonomik näherbringen wird.“ Prof. Dr. Iris Bohnet, Harvard University „Dem Autor gelingt es, die Grundzüge der modernen Verhaltensökonomik mit den komplexen Herausforderungen des Risikomanagements zu verbinden. Diese Perspektive ermöglicht einen interessanten Zugang zur Identifikation und Einschätzung von Risiken.“ Klaus Rosenfeld, CEO Schaeffler AG „Nicht Wissen, sondern Realisieren ist Macht. Diesen Glaser-Text zu exekutieren, garantiert Sicherheit.“ Prof. Dr. h. c. mult. Reinhold Würth, Stiftungsaufsichtsratsvorsitzender der Würth-Gruppe „Dieses Buch wird Ihren Blick auf das Management verändern!“ Prof. Dr. Herbert Henzler, ehem. European Chairmen McKinsey & Company Der Autor Dr. Christian Glaser promovierte im Themengebiet Risikomanagement und verantwortete diesen Bereich mehrere Jahre bei einem namhaften Finanzdienstleister.


Book
Suicidal crises in unipolar depression : How do non-drug interventions impact their management? : iQWiG reports - commission no. HT17-03
Author:
Year: 2019 Publisher: Koln, Germany : Institute for Quality and Efficiency in Health Care (IQWiG),

Loading...
Export citation

Choose an application

Bookmark

Abstract

RESEARCH QUESTIONS OF THE HTA REPORT: The aims of this investigation are to - assess the benefit of (1) crisis intervention programmes/services or (2) psychosocial interventions (technology based or not) in outpatient care in comparison with a different non-drug therapy, drug therapy, inpatient treatment, or no therapy / waiting list in adult suicidal patients with unipolar depression with regard to patient-relevant outcomes, - determine the costs incurred by (1) crisis intervention programmes/services or (2) psychosocial interventions (technology based or not) in outpatient care in comparison with a different non-drug therapy, drug therapy, inpatient treatment, or no therapy / waiting list in adult suicidal patients with unipolar depression (intervention costs), - assess the cost effectiveness of (1) crisis intervention programmes/services or (2) psychosocial interventions in outpatient care (technology based or not) in comparison with another non-drug therapy, drug therapy, inpatient treatment, or no therapy / waiting list in adult suicidal patients with unipolar depression was well as - review ethical, social, legal, and organizational aspects associated with the medical interventions. CONCLUSION OF THE HTA REPORT (SEE CHAPTER 9): To answer the question submitted to ThemenCheck, "Suicidal crises in unipolar depression: How do non-drug measures impact their management?", the following interventions were investigated: (1) crisis intervention programmes/services in outpatient care and (2) psychosocial interventions in outpatient care, namely (i) psychotherapeutic strategies for preventing suicide and (ii) suicide preventive follow-up services and contact offers. Despite this initially broad definition of interventions to be investigated in the outpatient care of adult suicidal patients with unipolar depression, only studies on cognitive behavioural therapy (CBT) were found, all of which focused on suicidality. These studies examined CBTs from the second and third "waves" of behavioural therapy (BT). The second wave of BT originated in the developments of the 1960s and 1970s, where classic BT was for the first time expanded to include cognitive aspects such as thoughts and convictions. In the 1980s, these considerations led to the approach of CBT. In the third wave of BT, the classic cognitive-behavioural concept, which largely focuses on restructuring processes, is expanded by the additional aspects of mindfulness and acceptance of difficult-to-control internal experiences. Additional conceptual differences concern the fundamental attitude and the patient-therapist relationship. CBT is a service already covered by the statutory health insurance. Four randomized controlled trials (RCTs) of moderate qualitative certainty of results were included. They primarily investigated the patient-relevant outcomes of anxiety, depressive symptoms, hopelessness, posttraumatic stress, suicidal ideation, and (follow-up) suicide attempts, each at the survey time points of 1, 3, 6, 18, and ≥ 18 months. With regard to the patient-relevant outcomes of suicidal ideation (6 months), suicide attempts (≥ 18 months), depressive symptoms (3, 6, and 18 months), and hopelessness (6 and 18 months), the results revealed an indication of (added) benefit of second-wave CBT in comparison with treatment as usual (TAU). With regard to the patient-relevant outcome of depressive symptoms, the results revealed a hint of (added) benefit at the survey time point of 1 month for third-wave CBT in comparison with TAU. These results are based on the data from one study. The currently still outstanding results from another study might supplement the results of this health technology assessment (HTA). For the outcomes of anxiety and posttraumatic stress (each at 3, 6, and 18 months), suicidal ideation (1, 3, and 18 months), depressive symptoms (1 month), and hopelessness (1 month and 3 months), no hint of (added) benefit of second-wave CBT versus TAU was found. With regard to third-wave CBT, for the outcome of depressive symptoms at the survey time point of 3 months, no hint of (added) benefit of third-wave CBT versus TAU was found. For the outcome of suicidal ideation at the time point of 1 month, no hint of (added) benefit of third-wave CBT versus TAU was found. For the following outcomes, data on second or third-wave CBT were either unavailable or unusable: all-cause mortality / overall survival, suicide mortality, physical functioning including activities of daily living / everyday functioning, inpatient admission, serious adverse events, discontinuation due to adverse events, health-related quality of life, and health-related social functioning, including occupational and social participation. Concerning second-wave CBT, data were also reported on social problem-solving ability, but they were disregarded due to reporting bias. However, patients in the initially conducted discussions highlighted the patient-relevant outcomes listed above as being particularly relevant. Therefore, there is clearly a need for further research, particularly high-quality RCTs, in this area. No studies were found with regard to cost effectiveness, and no conclusion can be drawn on this topic. To generate more evidence in this area as well, future investigations might concurrently collect data on both effectiveness as well as resource use and the costs of the intervention and comparator treatment. The costs listed in the present report are stated as ranges for patients with mild and severe disease courses. They range from EUR188.67 per treatment case for solely drug-based treatment to EUR2684.14 for one-on-one short-term outpatient therapy, and up to EUR15,314.23 for long-term outpatient therapy. However, comparability between the costs of the individual interventions per patient or per patient and treatment case is limited since their separate analyses do not fully reflect the realities of care. Depressive disorders differ widely between individuals in terms of their severity and course; therefore, actual costs might be lower or higher than those presented herein. Interventions other than CBT, including some low-threshold interventions such as telephone counselling or internet-based services, were also mentioned both in the focus groups and in the literature. Due to a lack of studies, however, it was not possible to compare these interventions to TAU. As already concluded by authors of other reviews, future studies should include such interventions as well and determine their effectiveness at early survey time points in order to ensure rapid treatment in crisis situations. The analysis of the ethical, social, legal, and organizational aspects has shown that they are highly relevant to the topic and, in particular, have a major impact on access to measures. Due to the complexity and multidimensional nature of the topic, the individual domains cannot and should not be analysed in isolation. Rather, their mutual interactions should be contemplated and discussed, as illustrated in the logical model.


Book
Suicidal crises in unipolar depression : How do non-drug interventions impact their management? : iQWiG reports - commission no. HT17-03
Author:
Year: 2019 Publisher: Koln, Germany : Institute for Quality and Efficiency in Health Care (IQWiG),

Loading...
Export citation

Choose an application

Bookmark

Abstract

RESEARCH QUESTIONS OF THE HTA REPORT: The aims of this investigation are to - assess the benefit of (1) crisis intervention programmes/services or (2) psychosocial interventions (technology based or not) in outpatient care in comparison with a different non-drug therapy, drug therapy, inpatient treatment, or no therapy / waiting list in adult suicidal patients with unipolar depression with regard to patient-relevant outcomes, - determine the costs incurred by (1) crisis intervention programmes/services or (2) psychosocial interventions (technology based or not) in outpatient care in comparison with a different non-drug therapy, drug therapy, inpatient treatment, or no therapy / waiting list in adult suicidal patients with unipolar depression (intervention costs), - assess the cost effectiveness of (1) crisis intervention programmes/services or (2) psychosocial interventions in outpatient care (technology based or not) in comparison with another non-drug therapy, drug therapy, inpatient treatment, or no therapy / waiting list in adult suicidal patients with unipolar depression was well as - review ethical, social, legal, and organizational aspects associated with the medical interventions. CONCLUSION OF THE HTA REPORT (SEE CHAPTER 9): To answer the question submitted to ThemenCheck, "Suicidal crises in unipolar depression: How do non-drug measures impact their management?", the following interventions were investigated: (1) crisis intervention programmes/services in outpatient care and (2) psychosocial interventions in outpatient care, namely (i) psychotherapeutic strategies for preventing suicide and (ii) suicide preventive follow-up services and contact offers. Despite this initially broad definition of interventions to be investigated in the outpatient care of adult suicidal patients with unipolar depression, only studies on cognitive behavioural therapy (CBT) were found, all of which focused on suicidality. These studies examined CBTs from the second and third "waves" of behavioural therapy (BT). The second wave of BT originated in the developments of the 1960s and 1970s, where classic BT was for the first time expanded to include cognitive aspects such as thoughts and convictions. In the 1980s, these considerations led to the approach of CBT. In the third wave of BT, the classic cognitive-behavioural concept, which largely focuses on restructuring processes, is expanded by the additional aspects of mindfulness and acceptance of difficult-to-control internal experiences. Additional conceptual differences concern the fundamental attitude and the patient-therapist relationship. CBT is a service already covered by the statutory health insurance. Four randomized controlled trials (RCTs) of moderate qualitative certainty of results were included. They primarily investigated the patient-relevant outcomes of anxiety, depressive symptoms, hopelessness, posttraumatic stress, suicidal ideation, and (follow-up) suicide attempts, each at the survey time points of 1, 3, 6, 18, and ≥ 18 months. With regard to the patient-relevant outcomes of suicidal ideation (6 months), suicide attempts (≥ 18 months), depressive symptoms (3, 6, and 18 months), and hopelessness (6 and 18 months), the results revealed an indication of (added) benefit of second-wave CBT in comparison with treatment as usual (TAU). With regard to the patient-relevant outcome of depressive symptoms, the results revealed a hint of (added) benefit at the survey time point of 1 month for third-wave CBT in comparison with TAU. These results are based on the data from one study. The currently still outstanding results from another study might supplement the results of this health technology assessment (HTA). For the outcomes of anxiety and posttraumatic stress (each at 3, 6, and 18 months), suicidal ideation (1, 3, and 18 months), depressive symptoms (1 month), and hopelessness (1 month and 3 months), no hint of (added) benefit of second-wave CBT versus TAU was found. With regard to third-wave CBT, for the outcome of depressive symptoms at the survey time point of 3 months, no hint of (added) benefit of third-wave CBT versus TAU was found. For the outcome of suicidal ideation at the time point of 1 month, no hint of (added) benefit of third-wave CBT versus TAU was found. For the following outcomes, data on second or third-wave CBT were either unavailable or unusable: all-cause mortality / overall survival, suicide mortality, physical functioning including activities of daily living / everyday functioning, inpatient admission, serious adverse events, discontinuation due to adverse events, health-related quality of life, and health-related social functioning, including occupational and social participation. Concerning second-wave CBT, data were also reported on social problem-solving ability, but they were disregarded due to reporting bias. However, patients in the initially conducted discussions highlighted the patient-relevant outcomes listed above as being particularly relevant. Therefore, there is clearly a need for further research, particularly high-quality RCTs, in this area. No studies were found with regard to cost effectiveness, and no conclusion can be drawn on this topic. To generate more evidence in this area as well, future investigations might concurrently collect data on both effectiveness as well as resource use and the costs of the intervention and comparator treatment. The costs listed in the present report are stated as ranges for patients with mild and severe disease courses. They range from EUR188.67 per treatment case for solely drug-based treatment to EUR2684.14 for one-on-one short-term outpatient therapy, and up to EUR15,314.23 for long-term outpatient therapy. However, comparability between the costs of the individual interventions per patient or per patient and treatment case is limited since their separate analyses do not fully reflect the realities of care. Depressive disorders differ widely between individuals in terms of their severity and course; therefore, actual costs might be lower or higher than those presented herein. Interventions other than CBT, including some low-threshold interventions such as telephone counselling or internet-based services, were also mentioned both in the focus groups and in the literature. Due to a lack of studies, however, it was not possible to compare these interventions to TAU. As already concluded by authors of other reviews, future studies should include such interventions as well and determine their effectiveness at early survey time points in order to ensure rapid treatment in crisis situations. The analysis of the ethical, social, legal, and organizational aspects has shown that they are highly relevant to the topic and, in particular, have a major impact on access to measures. Due to the complexity and multidimensional nature of the topic, the individual domains cannot and should not be analysed in isolation. Rather, their mutual interactions should be contemplated and discussed, as illustrated in the logical model.


Book
A workbook of ethical case scenarios in applied behavior analysis
Authors: ---
ISBN: 0128158948 012815893X 9780128158944 9780128158937 Year: 2019 Publisher: London

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Macroeconomic Survey Expectations
Author:
ISBN: 3319972235 3319972227 Year: 2019 Publisher: Cham : Springer International Publishing : Imprint: Palgrave Macmillan,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Why should we be interested in macroeconomic survey expectations? This important book offers an in-depth treatment of this question from a point of view not covered in existing works on time-series econometrics and forecasting. Clements presents the nature of survey data, addresses some of the difficulties posed by the way in which survey expectations are elicited and considers the evaluation of point predictions and probability distributions. He outlines how, from a behavioural perspective, surveys offer insight into how economic agents form their expectations. Michael Clements is Professor of Econometrics at the ICMA Centre, Henley Business School, University of Reading, UK. He is Series Editor of Palgrave Texts in Econometrics and Palgrave Advanced Texts in Econometrics, and has published extensively on time series econometrics, modelling and forecasting. .


Book
La médecine comportementale en actes : comment elle peut améliorer notre espérance et notre qualité de vie
Authors: ---
ISBN: 2876716178 9782876716179 Year: 2019 Publisher: Paris: Frison-Roche,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Quatrième de couverture : "Les solutions proposées par la médecine comportementale intéressent à la fois les troubles ou les souffrances qui entraînent des maladies ou les maladies elles-mêmes, génératrices de souffrances et de troubles. Que ce soit en amont ou en aval, ces troubles altèrent à la fois notre qualité et notre espérance de vie. Qu'il s'agisse de stress, d'obésité, d'épuisement professionnel (burn out), de sédentarité, tous ces états peuvent être à l'origine de graves accidents, notamment cardiaques. Que dire des addictions au tabac ou à l'alcool, que dire des douleurs attachées au vieillissement et comment supporter des états chroniques comme le cancer ou un Alzheimer ? Et pourtant ces troubles pourraient passer sous notre contrôle et être à notre main grâce à l'apprentissage de moyens développés par la Médecine Comportementale Personnelle dont le Professeur Jean Valty nous explique les principes (comment ça fonctionne ?) avec de nombreuses applications (en cardiologie, en termes d'addiction, ou pour soulager des épisodes de vie marqués par des douleurs). Faites un essai de ces nouvelles méthodes que Jean Valty, cardiologue et enseignant, a su rendre si profitables à notre santé et à notre bien-être."


Multi
Behavioral interventions in schools : evidence-based positive strategies
Authors: ---
ISBN: 9781433830716 143383071X Year: 2019 Publisher: Washington, DC American Psychological Association

Loading...
Export citation

Choose an application

Bookmark

Abstract

"As rates of Autism Spectrum Disorder (ASD) diagnoses continue to rise, the need for evidence-based classroom interventions has never been greater. This fully updated text shows psychologists how to assess and implement interventions that target students with ASD and other mental health disorders. Contributors also describe how to use cognitive behavior therapy to treat a variety of symptoms and behaviors. This book provides school psychologists, counselors, social workers, administrators, and teachers with the tools they need to succeed in today's classroom"--


Book
Clinical Psychopharmacology : An Update
Authors: --- ---
ISBN: 9811320926 9811320918 Year: 2019 Publisher: Singapore : Springer Singapore : Imprint: Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

This book provides practical information on how to use various psychotropic drugs in clinical practice, focusing on their mechanisms of action on receptors and enzymes in the brain. Divided into 11 chapters, it covers all main drug classes, with a dedicated chapter each on special populations and upcoming drugs. All the drugs discussed are presented in the same design format in order to facilitate rapid access to information. Specifically, each drug is individually divided into sections - its history and introduction, classification, pharmacological action, doses, drug interactions, indications, side effects and special populations. Only the essential facts about each drug have been included, so as to make the content concise and to avoid dilution of important information. To aid with review, key points are summarized at the end of each chapter.

Listing 1 - 10 of 484 << page
of 49
>>
Sort by